GLP ‐1 medication and weight loss: Barriers and motivators among 1659 participants managed in a virtual setting
Authors' conclusion
These findings underscore the importance of addressing patient-specific motivators and barriers during consultations to optimise outcomes and ensure sustainable weight loss strategies in clinical practice. Tailored approaches to GLP-1 treatment plans and support can help ensure sustainable weight loss strategies and improve patient adherence in clinical practice.
Study context
- Population
- Individuals using GLP-1 medications (GLP-1s) for weight loss, managed in a virtual setting
- Participants
- 1,659 individuals
- Outcome
- Experiences, motivators, barriers and reasons for discontinuation of GLP-1s for weight loss
Methodological detailssurveys, virtual setting
- Surveys
- Virtual setting
Main finding
As reported in the abstract
Had attempted weight loss for >10 years before starting GLP-1s
55%
Observational data: associations, not effects.
Original publication
GLP ‐1 medication and weight loss: Barriers and motivators among 1659 participants managed in a virtual setting. Diabetes Obes Metab. Published 21 April 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →